How to Manage Impact of Coronavirus (COVID-19) for Global Pharma and Biotech Continuity

Danielle DeLucy

Danielle DeLucy, MS, is Keynote speaker at ComplianceKey. She is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Danielle began her QA career as a Quality Control Pharmaceutical Microbiolo........

Overview

Attend this webinar to understand how the COVID-19 pandemic can affect manufacturing operations, employee safety and how to be flexible and creative in these uncertain times when it comes to business continuity.

Why should you attend this webinar?

The pharmaceutical world is mostly staying the course during the unprecedented conditions of the world as we are all living through the COVID-19 pandemic, but that doesn't mean there aren't measures that can be taken to make the workplace environment to continue to operated seamlessly and most importantly safely.

This course will help attendees understand how the COVID-19 pandemic can affect manufacturing operations, employee safety and how to be flexible and creative in these uncertain times when it comes to business continuity.

Key Learning

Identify how COVID-19 can affect your business
Learn how to manage the workforce changes
Learn ways to communicate more effectively during the pandemic
Streamline employee interaction
Identify ways of working more creatively

Areas Covered in the Session:

Background - How did this become a pandemic?

COVID-19 virus information
Means of infection

Employee Engagement / Interaction

Proper communication
Effects on business Units
Travel Restrictions
Communication Changes
How to continue maintaining compliance - deviations, CAPAs, document reviews, etc.